Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04735575
Title A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shanghai EpimAb Biotherapeutics Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.